Kezar Life Sciences buy HC Wainwright
Start price
27.11.23
/
50%
€0.80
Target price
27.11.24
€18.27
Performance (%)
-25.63%
Price
25.07.24
€0.60
Summary
This prediction is currently active. The prediction for Kezar Life Sciences disappoints with a performance of -25.63%. This prediction currently runs until 27.11.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Kezar Life Sciences | -5.556% | -5.556% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by HC_Wainwright for this prediction
In the thread Kezar Life Sciences diskutieren
Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Ratings data for KZR provided by MarketBeat
Stopped prediction by HC_Wainwright for Kezar Life Sciences
Kezar Life Sciences
Start price
Target price
Perf. (%)
€0.71
10.05.24
10.05.24
€18.56
10.05.25
10.05.25
-14.79%
25.07.24
25.07.24
Kezar Life Sciences
Start price
Target price
Perf. (%)
€0.81
04.12.23
04.12.23
€18.42
04.12.24
04.12.24
-28.57%
25.07.24
25.07.24
Kezar Life Sciences
Start price
Target price
Perf. (%)
€0.89
12.10.23
12.10.23
€18.90
12.10.24
12.10.24
-32.02%
25.07.24
25.07.24
Kezar Life Sciences
Start price
Target price
Perf. (%)
€1.05
25.09.23
25.09.23
€18.82
25.09.24
25.09.24
-43.33%
25.07.24
25.07.24